Total planned funding: $195,648,309
Allocations
Countries/Regions
| Eswatini | $195,648,309 |
Organizational Types
| Private Contractor | $46,056,696 |
| University | $40,386,426 |
| NGO | $36,972,670 |
| Unknown | $35,789,535 |
| Own Agency | $21,700,691 |
| Multi-lateral Agency | $6,532,042 |
| Host Country Government Agency | $5,696,615 |
| FBO | $1,538,242 |
| Implementing Agency | $590,000 |
| Other USG Agency | $385,392 |
Program Areas
| Care | $61,923,523 |
| Treatment | $46,230,672 |
| Prevention | $38,159,106 |
| Governance and Systems | $22,230,394 |
| Management and Operations | $13,975,366 |
| Testing | $13,129,248 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $34,030,266 |
| HBHC: Care: Adult Care and Support | $28,619,813 |
| HKID: Care: Orphans and Vulnerable Children | $16,671,740 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $14,636,027 |
| HVMS: Management and Operations | $13,975,366 |
| HVCT: Testing: HIV Testing and Counseling | $13,129,248 |
| HVTB: Care: TB/HIV | $11,927,191 |
| HVSI: Strategic Information | $11,011,719 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $9,403,084 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $8,999,476 |
| HTXD: Treatment: ARV Drugs | $8,697,898 |
| OHSS: Health Systems Strengthening | $7,908,587 |
| PDCS: Care: Pediatric Care and Support | $4,704,779 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $4,406,733 |
| PDTX: Treatment: Pediatric Treatment | $3,502,508 |
| HLAB: Laboratory Infrastructure | $3,310,088 |
| HMBL: Biomedical Prevention: Blood Safety | $713,786 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$36,109,141
Countries/Regions
Not Available:
$35,789,535
Countries/Regions
USG Aggregated Agencies:
$21,700,691
Countries/Regions
Pact, Inc.:
$21,399,931
Countries/Regions